TAMPA, Fla. – SynDaver, a leading developer of synthetic human and animal models used for education, surgical simulation and medical device testing, significantly increased the size of their sales team in 2019 and is planning more additions in 2020 to meet rising demands.
In 2019, the company experienced an increased demand in the education sector driven by k-12 educators looking for superior technologies to engage students in sciences, technology and engineering. As a result, SynDaver tripled its sales team from seven to 21 during the fourth quarter of last year, and is planning to add another 15 territory representatives during the first quarter of 2020.
The expansion began last April when Allan Weber joined SynDaver’s executive team as vice president of sales and marketing.
Weber, who has a background in the pharmaceutical and medical industries was previously the founder and CEO of Bio-Ess Laboratories®, LLC, a medical biotechnology company involved in biopharmaceutical production and cell-based research.
Prior to this, Weber founded Essential Pharmaceuticals, LLC, which focused on organ protection and preservation in the organ transplant and cardiothoracic surgery fields. He served as the company’s CEO and led a successful exit for this business after 11 years of growth, netting his investors 6.7 times their capital in 2016.
“When I joined SynDaver last Spring, the company was just beginning to experience increased demand, so we needed to quickly build the infrastructure and personnel required to effectively support our customers,” said Weber. “One of the first things I did was develop a rigorous process to recruit highly qualified and experienced sales representatives and territory sales managers. That process has helped us find some of the best and brightest talent in our vertical markets.”
With an IPO planned for late 2020 or early 2021, further expansion seems likely as the year progresses.
“I am very excited to have Allan on my team; not just for his sales experience but also for his general business acumen and experience with rapid-growth stage companies like ours,” said Dr. Christopher Sakezles, founder and CEO of SynDaver. “I am confident he will continue to build a successful team as we move forward.”
SynDaver’s synthetic humans, animal models and task trainers simulate the anatomy of live patients in great detail, including individual muscles, tendons, veins, arteries, nerves and organ systems. The company’s patented synthetic tissues are made of water, fibers and salts. Each of these non-toxic, non-latex tissues has been validated against the relevant living tissue for mechanical and physical properties.
For more information about SynDaver or the company’s products, visit https://syndaver.com/.
About SynDaver
Headquartered in Tampa, SynDaver is the world’s leading manufacturer of hyper-realistic, synthetic human and animal models for medical education, training and surgical simulation. SynDaver’s synthetic bodies mimic live tissue properties and are used by high schools, colleges and universities, hospitals, medical device companies and the military for training, testing and validation. SynDaver has the world’s largest database of live-tissue properties. Made from a proprietary formula of water, salts and fibers, the company holds 15 patents on their materials, processes and the related products. SynDaver has more than 100 employees at its facilities in the U.S. and is planning additional facilities in Europe, China, Brazil and India. SynDaver products have been lauded by industry experts and earned a cult following after appearances on ABC’s Shark Tank, MythBusters, Grey’s Anatomy and the series finale of CSI. For more information on SynDaver or their product offerings, visit http://SynDaver.com.
For media-related inquiries, please contact our PR firm at 813.279.8335 or by emailing news@judgepr.com.
